These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7425849)

  • 1. Relationship between enzymatic modifications of serum low density lipoproteins and their haemagglutination inhibiting activity towards Sindbis virus.
    Mastromarino P; Seganti L; Orsi N
    Arch Virol; 1980; 65(1):37-44. PubMed ID: 7425849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation by affinity chromatography of human very low and low density lipoproteins inhibiting Sindbis virus haemagglutination.
    Seganti L; Mastromarino P; De Stasio A; Sinibaldi L; Valenti P; Orsi N
    Acta Virol; 1980 Sep; 24(5):311-6. PubMed ID: 6108058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of lipid components of human serum lipoproteins involved in the inhibition of Sindbis virus infectivity, hemagglutination, and hemolysis.
    Mastromarino P; Conti C; Rieti S; Orsi N
    Arch Virol; 1988; 103(3-4):243-52. PubMed ID: 2463824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of lipids in the interaction of Sindbis virus with goose erythrocytes.
    Mastromarino P; Conti C; Rieti S; Orsi N
    Microbiologica; 1989 Apr; 12(2):113-20. PubMed ID: 2747550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the activities in inhibition of haemagglutination by different togaviruses for human serum lipoproteins and their constituents.
    Shortridge KF; Ho WK
    J Gen Virol; 1976 Dec; 33(3):523-7. PubMed ID: 187726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoproteins as inhibitors of haemafflutination by rubella virus.
    Ho WK
    Lipids; 1977 Jan; 12(1):85-91. PubMed ID: 189156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of carbohydrates in the manifestation of the hemagglutinating and neuraminidase activities of the influenza virus].
    Berezin VE; Kolesnikov VV; Kharitonenkov IG
    Vopr Virusol; 1979; (6):624-31. PubMed ID: 43031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of sindbis virus as a means of checking complete elimination of unspecific inhibitors in the rubella hemagglutination inhibition test (author's transl)].
    Schneweis KE; Wolff MH; Marklein G
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):75-87. PubMed ID: 4377637
    [No Abstract]   [Full Text] [Related]  

  • 9. Human serum lipoproteins as inhibitors of haemagglutination for selected togaviruses.
    Shortridge KF; Ho WK
    J Gen Virol; 1974 Apr; 23(1):113-6. PubMed ID: 4364873
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of glycosylation on haemagglutination and immunological reactivity of rubella virus.
    Ho-Terry L; Cohen A
    Arch Virol; 1984; 79(3-4):139-46. PubMed ID: 6696635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody against viruses in maternal and cord sera: non-specific inhibitors are found to higher titre on the maternal side of the circulation.
    Griffiths PD; Girdhar D; Fisher-Hoch S; Race MW; Heath RB
    J Hyg (Lond); 1984 Jun; 92(3):297-301. PubMed ID: 6736640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.
    Chanas AC; Gould EA; Clegg JC; Varma MG
    J Gen Virol; 1982 Jan; 58 Pt 1():37-46. PubMed ID: 7142968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lipids in the serum lipoproteins as inhibitors of hemagglutination by Japanese encephalitis virus.
    Ho WK; Shortridge KF
    Jpn J Med Sci Biol; 1976 Oct; 29(5):283-7. PubMed ID: 1011379
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum-treatment in the rubella hi-test by menas of silicic acid (author's transl)].
    Steinmann J
    Zentralbl Bakteriol Orig A; 1977 Oct; 239(2):157-61. PubMed ID: 201128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absence of a role for the carbohydrate moiety in the binding of apolipoprotein B to the low density lipoprotein receptor.
    Shireman RB; Fisher WR
    Biochim Biophys Acta; 1979 Mar; 572(3):537-40. PubMed ID: 219898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.
    Parthasarathy S; Steinbrecher UP; Barnett J; Witztum JL; Steinberg D
    Proc Natl Acad Sci U S A; 1985 May; 82(9):3000-4. PubMed ID: 3857630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic probes of lipoprotein structure. Hydrolysis of human serum low density lipoprotein-2 by phospholipase A2.
    Aggerbeck LP; Kézdy FJ; Scanu AM
    J Biol Chem; 1976 Jun; 251(12):3823-30. PubMed ID: 180009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of intracellular proteinases and glycosidases in the degradation of the 'large glycoprotein' responsible for the neuraminidase and hemagglutinating activity of the Newcastle disease virus].
    Tsvetkova IV; Chemm LV
    Vopr Med Khim; 1976; 22(2):266-9. PubMed ID: 1025889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SA-11 rotavirus binding to human serum lipoproteins.
    Superti F; Seganti L; Marchetti M; Marziano ML; Orsi N
    Med Microbiol Immunol; 1992; 181(2):77-86. PubMed ID: 1328829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins.
    Korotaeva AA; Golovanova NK; Vlasik TN; Yanushevskaya EV; Tsibulsky VP; Yakushkin VV; Tvorogova MG; Morozkin AD; Prokazova NV
    Biochemistry (Mosc); 1998 Dec; 63(12):1430-7. PubMed ID: 9916162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.